We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF

219 hedge funds and large institutions have $743M invested in ARK Genomic Revolution ETF in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 55

0.32% less ownership

Funds ownership: 72.38%72.06% (-0.32%)

8% less funds holding

Funds holding: 239219 (-20)

13% less capital invested

Capital invested by funds: $854M → $743M (-$111M)

26% less call options, than puts

Call options by funds: $79.9M | Put options by funds: $108M

32% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 41

Holders
219
Holders Change
-20
Holders Change %
-8.37%
% of All Funds
2.68%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.02%
New
28
Increased
60
Reduced
55
Closed
41
Calls
$79.9M
Puts
$108M
Net Calls
-$28.1M
Net Calls Change
+$211M
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
26
Jane Street
New York
$2.55M -$14.2M -484,079 -83%
Cambridge Investment Research Advisors
27
Cambridge Investment Research Advisors
Iowa
$2.29M -$135K -4,612 -5%
HCS
28
Himension Capital (Singapore)
Singapore
$2.25M +$2.49M +85,164 New
FDCDDQ
29
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.16M +$21.1K +721 +0.9%
Baird Financial Group
30
Baird Financial Group
Wisconsin
$1.94M -$1.25M -42,823 -37%
CCA
31
Clearwater Capital Advisors
Illinois
$1.91M -$17.2K -589 -0.8%
Walleye Trading
32
Walleye Trading
New York
$1.88M -$523K -17,849 -20%
Commonwealth Equity Services
33
Commonwealth Equity Services
Massachusetts
$1.79M -$125K -4,271 -6%
Mariner
34
Mariner
Kansas
$1.58M +$177K +6,053 +11%
GS
35
GTS Securities
Florida
$1.47M +$638K +21,776 +64%
Wealthfront Advisers
36
Wealthfront Advisers
California
$1.44M +$74.5K +2,544 +5%
SA
37
Sanctuary Advisors
Indiana
$1.4M +$43.8K +1,494 +3%
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$1.4M -$876K -29,921 -36%
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$1.37M -$11.5M -393,734 -88%
Hudson Bay Capital Management
40
Hudson Bay Capital Management
Connecticut
$1.32M -$2.64M -90,000 -64%
MWM
41
Moran Wealth Management
Florida
$1.3M +$639K +21,811 +80%
Two Sigma Investments
42
Two Sigma Investments
New York
$1.26M -$4.98M -169,900 -78%
Envestnet Asset Management
43
Envestnet Asset Management
Illinois
$1.26M +$228K +7,786 +20%
EH
44
Equitable Holdings
New York
$1.24M -$7.32K -250 -0.6%
Group One Trading
45
Group One Trading
Illinois
$1.21M +$842K +28,765 +168%
Stifel Financial
46
Stifel Financial
Missouri
$1.18M -$251K -8,569 -16%
HA
47
Hanover Advisors
South Carolina
$1.14M +$216K +7,376 +21%
PP
48
Prudential plc
United Kingdom
$1.11M -$167K -5,700 -12%
IWM
49
IHT Wealth Management
Illinois
$1.07M +$456K +15,557 +62%
BCM
50
Brookstone Capital Management
Illinois
$1.04M -$128K -4,358 -10%

ARKG Hedge Fund Activity: Q1 2026 in Review

219 of the 8,172 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2026, worth a combined $743M — down 13% from $854M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of ARKG and 28 opened new positions — a net loss of 13 holders — while 55 trimmed existing stakes and 60 added.

The largest buyer was JP Morgan Chase, adding an estimated $61M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $59.2M.

  • 219 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2026, down from 239 in Q4 2025.
  • Funds reported $743M of ARK Genomic Revolution ETF stock for Q1 2026, down 13% quarter-over-quarter.
  • 28 funds opened new ARK Genomic Revolution ETF positions in Q1 2026 and 41 closed out, a net change of -13 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q1 2026 was JP Morgan Chase, an estimated $61M added.
  • The largest ARK Genomic Revolution ETF seller in Q1 2026 was BNP Paribas Financial Markets, an estimated $59.2M sold.

Based on aggregated 13F filings for Q1 2026.